This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.
The European Union’s proposed ban on “forever chemicals” is expected to become l...
AstraZeneca is furthering its presence in China by gaining complete control of F...
BridgeBio revealed Thursday that prescriptions for its recently approved rare he...
A French biotech focused on developing genetic medicines for neurological condit...
Zealand Pharma investors eager for news of a partnering deal for the Danish grou...
An attorney for the federal government said the FDA “acted well within its autho...
Hims & Hers bought an at-home lab testing company as it branches out into other ...
Attorneys for the government and laboratory diagnostics trade groups have gather...
Nearly a year ago, bioengineering professor Patrick Hsu asked: “Is DNA all you n...
Ascletis Pharma’s oral GLP-1 allowed patients in an early-stage obesity trial to...
Plus, news about Harmony Biosciences and Reverb Therapeutics: Genuine Biotec...
WASHINGTON — Over 500 pharma executives, lobbyists, consultants and other indust...
This is the first in a series of stories from Endpoints News that looks at the f...
The FDA has prohibited two API manufacturers from shipping products to the US, w...
In his first speech to staff as newly confirmed HHS Secretary, Robert F. Kennedy...
Epitopea has inked a license and research collaboration with Merck to discover n...